Workshop on use of data in cross-border biomedical research – Summary report is now available

The FEAM European Biomedical Policy Forum workshop on “Use of data a in cross-border biomedical research: what are the challenges ahead for Europe?”  took place on 20 November 2017 in Brussels. The summary report is now available.

The workshop was organised against the backdrop of the General Data Protection Regulation (GDPR), which will come into force on 25 May 2018 and may have important consequences for cross-border biomedical research.

The aims of the workshop were to stimulate debate on the following topics:

1. What are the concerns of different stakeholders over the GDPR legislation and how will it impact cross-border biomedical research in Europe? Which solutions should be put in place?
2. What is the EU doing to support the use of personal data to advance biomedical research?What is the role of the European Commission and Member States in promoting compatibility and avoid fragmentation between national laws?

For more information and to access the speakers’ presentations, please visit the event page

About the FEAM European Biomedical Policy Forum

The FEAM European Biomedical Policy Forum provides a platform for discussion on key policy issues for the biomedical community.

The Forum is an initiative from the Federation of European Academies of Medicine (FEAM). It aims to bring together representatives from academia, research charities, industry, European and national trade associations and professional bodies, regulators, public health bodies, and patient and consumers groups.

To learn more about the FEAM European Biomedical Policy Forum, please consult the FEAM Forum page

This workshop was funded by the UK Academy of Medical Sciences using a grant from the UK’s Department of Business, Energy & Industrial Strategy (BEIS).